Inventor · disambiguated record
Kwok Yin Tsang
Also filed as: TSANG KWOK YIN
26 granted patents·2 pending applications·187 citations·filing 1998–2025
95Inventor score
Top patents by PatentIndex Score
28 records- 0192US10023597B2RNA interference agents for p21 gene modulationNITTO DENKO CORP·Filed 2017·Granted Jul 17, 2018·6 cites·9 claims
- 0291US9695206B2RNA interference agents for P21 gene modulationNITTO DENKO CORP·Filed 2015·Granted Jul 4, 2017·6 cites·8 claims
- 0391US6403638B12,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptorsALLERGAN SALES INC·Filed 2000·Granted Jun 11, 2002·45 cites·20 claims
- 0488US10167253B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2016·Granted Jan 1, 2019·6 cites·16 claims
- 0586US11384051B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2018·Granted Jul 12, 2022·2 cites·14 claims
- 0685US6147224A2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptorsALLERGAN SALES INC·Filed 1998·Granted Nov 14, 2000·69 cites·27 claims
- 0782US11413243B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2018·Granted Aug 16, 2022·1 cites·23 claims
- 0882US7476673B2Disubstituted chalcone oximes as selective agonists of RARγ retinoid receptorsALLERGAN INC·Filed 2004·Granted Jan 13, 2009·20 cites·38 claims
- 0981US7226951B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2004·Granted Jun 5, 2007·13 cites·4 claims
- 1079US12319643B2Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2022·Granted Jun 3, 2025·0 cites·12 claims
- 1179US9636411B2Large scale process for preparing poly (glutamyl-glutamate) conjugatesNITTO DENKO CORP·Filed 2013·Granted May 2, 2017·4 cites·41 claims
- 1277US2025250226A1Ionizable compounds and compositions and uses thereofNITTO DENKO CORP·Filed 2025·Application pending·0 cites
- 1376US12440445B2Fusogenic compounds for delivery of biologically active moleculesNITTO DENKO CORP·Filed 2022·Granted Oct 14, 2025·0 cites·11 claims
- 1471US7468391B2Methods for treating retinoid responsive disorders using selective inhibitors of CYP26A and CYP26BALLERGAN INC·Filed 2004·Granted Dec 23, 2008·5 cites·12 claims
- 1570US6740676B24-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activityALLERGAN INC·Filed 2002·Granted May 25, 2004·5 cites·32 claims
- 1668US6683092B1[3-(c5-14alkyl-2-oxo-1,2,3,4-tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-phenyl and [3-(c5-14alkyl-2-oxo-1,2,3,4- tetrahydro-quinolin-6-yl)-3-oxo-propenyl]-heteroaryl derivatives having anti-tumor activityALLERGAN INC·Filed 2003·Granted Jan 27, 2004·4 cites·31 claims
- 1765US10405749B2RNA agents for P21 gene modulationNITTO DENKO CORP·Filed 2015·Granted Sep 10, 2019·0 cites·9 claims
- 1861US6936636B25-[phenyl-tetrahydronaphthalene-2-yl dihydronaphthalen-2-yl and heteroaryl-cyclopropyl]-pentadienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted Aug 30, 2005·1 cites·42 claims
- 1958US7432388B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2007·Granted Oct 7, 2008·0 cites·4 claims
- 2056US9839694B2Reduction of endotoxins from polyanionic polymer conjugatesNITTO DENKO CORP·Filed 2013·Granted Dec 12, 2017·0 cites·42 claims
- 2156US7638648B2Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the sameALLERGAN INC·Filed 2007·Granted Dec 29, 2009·0 cites·10 claims
- 2254US7253319B2Disubstituted chalcone oximes having RARγ retinoid receptor antagonist activityALLERGAN INC·Filed 2004·Granted Aug 7, 2007·0 cites·18 claims
- 2353US7351737B24-[(8-substituted)-6-chromanoyl]-and 4-[8-substituted)-chroman-6-YL-ethynyl]-benzoic and phenylacetic acids, their esters and salts having cytochrome P450RAI inhibitory activityALLERGAN INC·Filed 2003·Granted Apr 1, 2008·0 cites·38 claims
- 2451US2011251143A1Stable elsamitrucin salt formulationsSPECTRUM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2544US9295728B2Co-polymer conjugatesNITTO DENKO CORP·Filed 2013·Granted Mar 29, 2016·0 cites·22 claims
- 2644US9078926B2Polymer conjugates with a linkerNITTO DENKO CORP·Filed 2013·Granted Jul 14, 2015·0 cites·19 claims
- 2742US6887896B17-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activityALLERGAN INC·Filed 2003·Granted May 3, 2005·0 cites·68 claims
- 2834US10080737B2Polymer-based hydrotropes for hydrophobic drug deliveryNITTO DENKO CORP·Filed 2015·Granted Sep 25, 2018·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Kwok Yin Tsang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →